🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are excited to announce the enrollment of our first patient in our Phase III Pivotal Study evaluating Investigational New Drug SkinTE for the treatment of diabetic foot ulcers. We are incredibly thankful for the patients and investigators. polarityte.com/news-media/pre…

Adding to the good news of enrolling our first patient, the FDA has just designated SkinTE a Regenerative Medicine Advanced Therapy. #RMATs are novel regenerative therapies that address unmet needs, which SkinTE demonstrated in our prior clinical data. polarityte.com/news-media/pre…

The boys are back together #AUA2022 The Johns Hopkins Brady Urological Institute

Atrogin protein and Wnt-beta catenin are increased in age related urethral sphincter fibrosis by Dr. Rajasekaran #AUA17

Dr. Joice presenting work on AUS component replacement. #smsna2017 The Johns Hopkins Brady Urological Institute

Dr. Bivalacqua Trinity J. Bivalacqua presenting the complex regulatory scheme of biological therapies The Johns Hopkins Brady Urological Institute #smsna2017

Dr. Bivalacqua presents final results of Phase I neourinary conduit trial. Very promising results but still needs optimization. #aua18 The Johns Hopkins Brady Urological Institute Trinity J. Bivalacqua Gregory Joice, M.D.

Dr. Liu shows preliminary preclinical results showing loss of function with penile Botox injections raising important questions. #AUA18 The Johns Hopkins Brady Urological Institute @jsexmed

Dr. Matz presents preclinical data showing sustained erectile improvement with off the shelf human placental stem cell. #AUA18 Wake Forest Urology @jsexmed

Shelby Powers from Dr. Hannan’s lab shows loss of regenerative capacity of pelvic ganglia neurons following radiation. #AUA18 Dr Johanna Hannan Shelby A. Powers MD MS @jsexmed